A New Approach to Vector-free CRISPR Editing Starting From Single Cells

Hosted in collaboration with InsideScientific and Scientist.com

Registration
Free
Qty
Join us to learn how CellEDIT can be used for targeted gene editing.

Recent advancements in gene editing have highlighted the importance of precision and control in the development of genetically modified cell lines. The CellEDIT service leverages a novel vector-free CRISPR editing approach, starting from single cells, to achieve high precision in gene editing. This method has proven effective in complex scenarios, such as multiplexing in CHO cells and executing precise deletions of distinct genomic elements, offering a significant leap forward in the field of genetic research.

In this webinar, Dr. Tobias Beyer, Chief Scientific Officer of Cytosurge, will provide a detailed overview of the CellEDIT workflow and show how this approach provides enhanced control over the editing process, supporting more complex CRISPR edits.

By attending this webinar, you'll gain valuable insights into:

  • The scientific principles of the unique vector-free CellEDIT approach, and how it uses intranuclear injection of CRISPR RNPs into single cells to enhance control over the editing process.
  • Case studies demonstrate efficient multiplexing in CHO cells, including simultaneously knocking out 3 genes in a single experiment.
  • Advanced CRISPR editing strategies, such as precise deletions and double guide techniques, and how these innovations can impact your research.

Don't miss this opportunity to gain insights into the vector-free CellEDIT approach and how it can transform your research and accelerate your progress.

Join the webinar now!
About the speaker:
Dr. Tobias Beyer is the Chief Scientific Officer at Cytosurge with 20 years combined research experience in molecular and cell biology. He obtained his PhD in Cell Biology from the ETH Zurich. After a postdoctoral fellowship at the LTRI in Toronto, he returned to ETH Zurich as junior group leader in the groups of Prof. Wutz and Prof. Corn. Here, he combined his expertise in cell biology, cell signaling and embryonic stem cells with genome engineering using the CRISPR/Cas9 technology.
At Cytosurge, together with the CellEDIT team, Tobias used his background in genome engineering and cell biology to further establish the cell line engineering process using the FluidFM technology.
 
Date & Time
Tuesday September 24, 2024
4:00 PM 5:00 PM (Europe/Zurich)
Location

InsideScientific

--InsideScientific--
--InsideScientific--
Get the direction
Organizer

Scientist.com

--Scientist.com--
SHARE

Find out what people see and say about this event, and join the conversation.